PT-141 (research designation Bremelanotide) is a melanocortin-receptor research compound.
Classification
PT-141 is a melanocortin receptor agonist acting at the MC3R and MC4R subtypes — the same receptor family studied with the melanotan compounds.
In research
Studied in the context of melanocortin-receptor and central nervous system signaling research. This describes researched mechanism for reference only — not outcomes or any application.
Specifications & verification
10mg lyophilized vial, ≥99% purity standard; store at -20°C. Independent, lot-matched HPLC COA (current lot CS-pt101105).
PT-141 is a research reference material for laboratory research use only. Not for human consumption.